Despite the significant upregulation of LINC01614 characterized here in GC along with previous reports in other cancers, the molecular mechanisms still are not clearly seen, and more explorations are also necessary to detect upstream or downstream effectors of LINC01614 in GC progression. The gene discussed is LINC01614; the disease is cancer.